Phase I/II Intraventricular DepoCyt (OD 06-2348) in Glioblastoma (76,730, 11/06).

Trial Profile

Phase I/II Intraventricular DepoCyt (OD 06-2348) in Glioblastoma (76,730, 11/06).

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Cytarabine (Primary) ; Temozolomide
  • Indications Astrocytoma; Brain cancer; Glioblastoma; Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 19 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 11 Feb 2013 Planned End Date changed from 1 Sep 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top